Diana Radovan PhD ELS

Plus Ultra Pharma

Diana Radovan PhD ELS acts as the Head of Regulatory Affairs Europe at Plus Ultra Pharma, the European division of Nobel Pharma Ltd Japan, a biotech company specialised in developing drugs and medical devices for rare and paediatric disorders. She has been working in the industry since 2011 in diverse global regulatory affairs and medical writing roles and across multiple therapeutic areas, in the consulting, CRO, and ‘big pharma’ environments. In addition, she is an EMWA PV SIG Committee Member.